---
title: "CJC-1295 vs Ipamorelin | PepTracker Pro"
description: "CJC-1295 and Ipamorelin both promote growth hormone release but act through different receptor pathways and produce distinct GH release patterns."
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "name": "PepTracker Pro",
      "url": "https://peptrackerpro.com",
      "logo": "https://peptrackerpro.com/favicon.png",
      "description": "Evidence-based educational resource dedicated to improving peptide research literacy.",
      "contactPoint": {
        "@type": "ContactPoint",
        "email": "hello@peptrackerpro.com",
        "contactType": "customer support"
      },
      "sameAs": []
    },
    {
      "@context": "https://schema.org",
      "@type": "Article",
      "headline": "CJC-1295 vs Ipamorelin",
      "description": "CJC-1295 and Ipamorelin both promote growth hormone release but act through different receptor pathways and produce distinct GH release patterns.",
      "dateModified": "2026-05-27",
      "author": {
        "@type": "Organization",
        "name": "PepTracker Pro Research Team",
        "url": "https://peptrackerpro.com"
      },
      "publisher": {
        "@type": "Organization",
        "name": "PepTracker Pro",
        "logo": {
          "@type": "ImageObject",
          "url": "https://peptrackerpro.com/favicon.png"
        }
      },
      "mainEntityOfPage": {
        "@type": "WebPage",
        "@id": "https://peptrackerpro.com/compare/cjc-1295-vs-ipamorelin"
      }
    }
  ]
---

[Skip to main content](#main)

**Educational information only.** This site does not provide medical advice. [Read full disclaimer](/disclaimer) 

[PepTracker Pro](/)

[Home](/)[Peptides](/peptides)[Compare](/compare)[Glossary](/glossary)[Blog](/blog)[Calculators](/calculators)[Start Here](/start)

[Open the App](https://app.peptrackerpro.com)

[Compare](/compare)/ CJC-1295 vs Ipamorelin 

**Research-only content.** This comparison is for educational purposes and does not constitute medical advice. [Read full disclaimer →](/research-disclaimer)

# CJC-1295 vs Ipamorelin

Last updated: 2026-05-27

-   CJC-1295 is a GHRH analog that stimulates growth hormone release from the pituitary; Ipamorelin is a ghrelin mimetic (GHRP) that acts on a different receptor.
-   CJC-1295 produces sustained GH elevation over hours; Ipamorelin produces shorter, more pulsatile GH release.
-   Ipamorelin is considered more selective with fewer effects on cortisol and prolactin compared to other GHRPs.
-   Both are studied for body composition, recovery, and age-related GH decline.
-   They are sometimes studied together due to potentially complementary mechanisms of GH secretion.

CJC-1295 and Ipamorelin both promote growth hormone release but act through different receptor pathways and produce distinct GH release patterns.

## Side-by-Side Comparison

Attribute

CJC-1295

Ipamorelin

What It Is

A growth hormone releasing hormone analog studied for stimulating growth hormone secretion.

A selective growth hormone secretagogue studied for targeted GH release with fewer side effects than other GH peptides.

Typical Research Focus

Muscle GrowthFat LossRecoverySleepAnti-Aging

Muscle GrowthFat LossRecoverySleepAnti-Aging

Proposed Mechanisms

-   Binds to GHRH receptors on anterior pituitary somatotrophs
-   Drug Affinity Complex (DAC) binds albumin, extending half-life to ~6–8 days
-   Stimulates pulsatile GH release, preserving natural secretion patterns

-   Binds ghrelin receptor (GHSR) on pituitary somatotroph cells to stimulate pulsatile GH release
-   Selective GH stimulation without significant cortisol, ACTH, prolactin, or aldosterone elevation
-   Dose-dependent GH response that preserves natural circadian GH pulsatility

Evidence Snapshot

Medium Evidence research peptide 

Medium Evidence research peptide 

Cautions

-   May affect blood sugar levels
-   Potential for water retention reported in studies
-   Not FDA-approved for any indication

-   Limited long-term human safety data
-   Not FDA-approved
-   May interact with other hormonal therapies

### CJC-1295

What It Is

A growth hormone releasing hormone analog studied for stimulating growth hormone secretion.

Research Focus

Muscle GrowthFat LossRecoverySleepAnti-Aging

Evidence

Medium Evidence 

Cautions

-   May affect blood sugar levels
-   Potential for water retention reported in studies
-   Not FDA-approved for any indication

### Ipamorelin

What It Is

A selective growth hormone secretagogue studied for targeted GH release with fewer side effects than other GH peptides.

Research Focus

Muscle GrowthFat LossRecoverySleepAnti-Aging

Evidence

Medium Evidence 

Cautions

-   Limited long-term human safety data
-   Not FDA-approved
-   May interact with other hormonal therapies

## When Researchers Compare Them

CJC-1295 and Ipamorelin are frequently discussed together in growth hormone research because they stimulate GH release through complementary pathways. CJC-1295, a growth hormone-releasing hormone (GHRH) analog, acts on the GHRH receptor to promote sustained GH secretion. Ipamorelin, a growth hormone-releasing peptide (GHRP), acts on the ghrelin receptor (GHS-R1a) to produce more targeted GH pulses.

Researchers note that Ipamorelin is considered one of the more selective GHRPs, meaning it tends to stimulate GH release without significantly affecting cortisol or prolactin levels — a distinction from older secretagogues like GHRP-6. CJC-1295, particularly the DAC (Drug Affinity Complex) variant, extends the half-life of GHRH signaling.

Some preclinical and early-phase research has explored whether combining GHRH analogs with GHRPs produces synergistic GH elevation, reflecting the body's natural dual-signal system for GH regulation.

## Peptide Profiles

[CJC-1295 Profile](/peptides/cjc-1295) [Ipamorelin Profile](/peptides/ipamorelin)

## Citations

1.  \[1\]  Teichman SL. et al. — Prolonged stimulation of growth hormone release by CJC-1295. J Clin Endocrinol Metab. 2006 [Source](https://pubmed.ncbi.nlm.nih.gov/)
2.  \[2\]  Teichman SL. et al. — Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. JCEM. 2006 [Source](https://pubmed.ncbi.nlm.nih.gov/16352683/)

### Explore Research Tools

Use calculators for reconstitution, dosing references, and more.

[Use PepTracker Pro Tools](/calculators)

## Related Peptides

### AOD-9604

Medium Evidence 

A modified fragment of human growth hormone studied for fat metabolism without growth-promoting effects.

[Fat Loss](/benefits/fat-loss)[Metabolism](/benefits/metabolism)[Joint Health](/benefits/joint-health)

[View Details](/peptides/aod-9604) [\+ Compare](/compare?select=aod-9604)[](https://app.peptrackerpro.com/?add=aod-9604)

### CJC-1295 (DAC)

Medium Evidence 

A long-acting GHRH analog with an extended half-life due to its Drug Affinity Complex modification.

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Sleep](/benefits/sleep)+1 more 

[View Details](/peptides/cjc-1295-dac) [\+ Compare](/compare?select=cjc-1295-dac)[](https://app.peptrackerpro.com/?add=cjc-1295-dac)

### DSIP

Low Evidence 

A neuropeptide studied for its role in sleep regulation and stress modulation.

[Sleep](/benefits/sleep)[Mood](/benefits/mood)[Anxiety Relief](/benefits/anxiety-relief)[Pain Relief](/benefits/pain-relief)

[View Details](/peptides/dsip) [\+ Compare](/compare?select=dsip)[](https://app.peptrackerpro.com/?add=dsip)

### GHRP-6

Medium Evidence 

A growth hormone secretagogue that also stimulates appetite through ghrelin receptor activation.

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Appetite Regulation](/benefits/appetite-regulation)

[View Details](/peptides/ghrp-6) [\+ Compare](/compare?select=ghrp-6)[](https://app.peptrackerpro.com/?add=ghrp-6)

### Sermorelin

Medium Evidence 

A GHRH analog previously FDA-approved for growth hormone deficiency diagnosis and treatment.

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Sleep](/benefits/sleep)[Recovery](/benefits/recovery)+1 more 

[View Details](/peptides/sermorelin) [\+ Compare](/compare?select=sermorelin)[](https://app.peptrackerpro.com/?add=sermorelin)

### Tesamorelin

High Evidence 

A GHRH analog FDA-approved for reducing visceral fat in HIV-associated lipodystrophy.

[Fat Loss](/benefits/fat-loss)[Muscle Growth](/benefits/muscle-growth)[Metabolism](/benefits/metabolism)[Anti-Aging](/benefits/anti-aging)

[View Details](/peptides/tesamorelin) [\+ Compare](/compare?select=tesamorelin)[](https://app.peptrackerpro.com/?add=tesamorelin)

[PepTracker Pro](/)

Educational peptide information and research tracking tools. Not medical advice.

#### Explore

-   [Peptide Directory](/peptides)
-   [Compare Peptides](/compare)
-   [Glossary](/glossary)
-   [Benefits](/benefits/sleep)

#### Learn

-   [Blog](/blog)
-   [Calculators](/calculators)
-   [Start Here](/start)
-   [About](/about)

#### Legal

-   [Editorial Policy](/editorial-policy)
-   [Research Disclaimer](/research-disclaimer)
-   [Disclaimer](/disclaimer)
-   [Privacy Policy](/privacy)
-   [Terms of Service](/terms)
-   [Contact](/contact)

© 2026 PepTracker Pro. Educational purposes only. Not medical advice. Always consult a licensed healthcare provider.